IP Library Assignment 024320/0741
Patent Assignment
Reel/Frame 024320/0741

Release of Security Interest

Recorded: 2010-05-03 Pages: 14
Assignors
PROLOG CAPITAL II, L.P.
Executed: 2010-04-29
CHARTER LIFE SCIENCES, L.P.
Executed: 2010-04-29
MEMPHIS BIOMED VENTURES II, L.P.
Executed: 2010-04-30
ALAFI CAPITAL COMPANY, LLC
Executed: 2010-05-02
APJOHN VENTURES FUND, LP
Executed: 2010-05-02
VECTIS LIFE SCIENCES FUND I, L.P.
Executed: 2010-05-02
WICKLINE, SAMUEL A., M.D.
Executed: 2010-05-02
1998 CO-INVESTING LLC
Executed: 2010-05-02
Assignee
KEREOS, INC.
4041 FOREST PARK AVE., ST. LOUIS, MISSOURI, 63108
Covered Properties (33)
Avidin-Biotin Conjugated Emulsions as a Site Specific Binding System
Patent: 5,690,907 →
Application: 08/488,743 →
Method of Mri Using Avidin-Biotin Conjugated Emulsions as a Site Specific Binding System
Patent: 5,780,010 →
Application: 08/647,277 →
Site Specific Binding System, Nuclear Imaging Compositions and Methods
Patent: 5,958,371 →
Application: 08/989,979 →
Site Specific Binding System, Imaging Compositions and Method
Patent: 5,989,520 →
Application: 09/026,216 →
Site Specific Binding System, Imaging Compositions and Methods
Patent: 6,548,046 →
Application: 09/404,963 →
Ligand-Targeted Emulsions Carrying Bioactive Agents
Patent: 6,676,963 →
Application: 09/697,796 →
Enhanced Ultrasound Detection with Temperature-Dependent Contrast Agents
Patent: 7,179,449 →
Application: 09/774,278 →
Publication: US 2002/0102216
Site Specific Binding System, Imaging Compositions and Methods
Patent: 6,821,506 →
Application: 10/036,317 →
Publication: US 2002/0168320
Paramagnetic Particles That Provide Improved Relaxivity
Patent: 6,869,591 →
Application: 10/153,395 →
Publication: US 2003/0185760
Blood Clot-Targeted Nanoparticles
Patent: 7,220,401 →
Application: 10/225,024 →
Publication: US 2003/0086867
Methods for Targeted Drug Delivery
Patent: 7,186,399 →
Application: 10/302,369 →
Publication: US 2003/0129136
Integrin Targeted Imaging Agents
Patent: 7,255,875 →
Application: 10/351,463 →
Publication: US 2004/0058951
Paramagnetic Particles That Provide Improved Relaxivity
Patent: 7,235,227 →
Application: 10/400,379 →
Publication: US 2003/0215392
Targeted Atherosclerosis Treatment
Patent: 7,803,374 →
Application: 10/492,749 →
Publication: US 2007/0010577
Blood Clot-Targeted Nanoparticles
Application: 10/544,857 →
Publication: US 2008/0247943
Efficacy and Safety of Targeted Particulate Agents with Decoy Systems
Application: 10/588,572 →
Publication: US 2008/0193372
Chelating Agents with Lipophilic Carriers
Patent: 7,279,150 →
Application: 10/765,299 →
Publication: US 2004/0248856
Emulsion particles for imaging and therapy and methods of use thereof
Application: 10/913,846 →
Publication: US 2005/0079131
Enhanced drug delivery
Application: 10/993,578 →
Publication: US 2005/0175541
Lipophilic Derivatives of Chelate Monoamides
Patent: 7,504,088 →
Application: 11/146,651 →
Publication: US 2006/0008417
Integrin Targeted Imaging Agents
Patent: 7,344,698 →
Application: 11/305,416 →
Publication: US 2006/0147380
Methods to ameliorate and image angioplasty-induced vascular injury
Application: 11/607,683 →
Publication: US 2007/0140965
Enhanced Ultrasound Detection with Temperature-Dependent Contrast Agents
Application: 11/677,040 →
Publication: US 2007/0255117
Targeted Mr Imaging Agents
Patent: 8,003,078 →
Application: 11/693,647 →
Publication: US 2007/0237721
Blood clot-targeted nanoparticles
Application: 11/796,064 →
Publication: US 2007/0202040
Detection and imaging of target tissue
Application: 11/796,415 →
Publication: US 2007/0258908
Combinations for Treatment of Neovasculature
Application: 11/865,603 →
Publication: US 2008/0138288
Chelating Agents with Lipophilic Carriers
Patent: 7,727,512 →
Application: 11/869,685 →
Publication: US 2008/0145311
Linkers for Anchoring Targeting Ligands
Patent: 7,998,462 →
Application: 11/872,984 →
Publication: US 2008/0305037
Methods of Imaging Employing Chelating Agents
Application: 11/944,271 →
Publication: US 2008/0241061
Integrin Targeted Imaging Agents
Patent: 7,566,442 →
Application: 11/971,818 →
Publication: US 2008/0175792
Nanoparticle Delivery Systems Comprising a Hydrophobic Core and a Lipid/Surfactant Layer Comprising a Membrane-Lytic Peptide
Patent: 7,943,168 →
Application: 12/043,063 →
Publication: US 2008/0274056
Combination Antitumor Therapies
Application: 12/160,091 →
Publication: US 2009/0317475
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 6, 2008
From: LANZA, GREGORY M.; WICKLINE, SAMUEL A.
To: BARNES-JEWISH HOSPITAL D/B/A THE JEWISH HOSPITAL OF ST. LOUIS
Reel/Frame 021630/0869 →
Release of Patent Security Agreement May 13, 2010
From: ABLECO FINANCE LLC
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 024380/0363 →
Security Agreement May 13, 2010
From: LANTHEUS MEDICAL IMAGING, INC.
To: HARRIS N.A., AS COLLATERAL AGENT
Reel/Frame 024390/0733 →
Assignment of Security Interest in Patents Jul 3, 2013
From: BMO HARRIS BANK N.A.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ASSIGNEE
Reel/Frame 030740/0335 →
Release of Security Interest in Certain Patents Mar 30, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: LANTHEUS HOLDINGS, INC.; LANTHEUS MEDICAL IMAGING, INC.; LANTHEUS MI REAL ESTATE, LLC
Reel/Frame 042115/0715 →